MEDANTA · Healthcare · Medical Care Facilities
Composite scorecard: 54/100 — Quality 62 · Valuation 24 · Growth 89 · Momentum 29
| Share price | ₹1,331.40 |
| Market cap | ₹30,592 Cr |
| P/E ratio | 59.5 |
| P/B ratio | 8.3 |
| ROE | 20.9% |
| ROCE | 17.1% |
| Dividend yield | 0.04% |
| Book value | ₹137.83 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹4,410 Cr | ₹554 Cr | 21.0% |
| 2025 | ₹3,692 Cr | ₹481 Cr | 24.0% |
| 2024 | ₹3,275 Cr | ₹478 Cr | 25.0% |
| 2023 | ₹2,710 Cr | ₹326 Cr | 24.0% |
| 2022 | ₹2,167 Cr | ₹196 Cr | 21.0% |
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology an